recent publications

• academic article

  • de Haan, H. G., Bezemer, I. D., Vossen, C. Y., van Hylckama Vlieg, A., Boehringer, S., Hasstedt, S. J., Levy, S., Rosendaal, F. R., Bovill, E. G. Genetic variants in Cell Adhesion Molecule 1 (CADM1): A validation study of a novel endothelial cell venous thrombosis risk factor Thrombosis Research  2014 134:1186-1192  DOI:10.1016/j.thromres.2014.09.018  PMID:25306186  PMCID:PMC4252856
  • Granger, C. B., Becker, R., Tracy, R. P., Califf, R. M., Topol, E. J., Pieper, K. S., Ross, A. M., Roth, S., Lambrew, C., Bovill, E. G., Grp, Gusto- I. Hemostasis Substudy Thrombin generation, inhibition and clinical outcomes in patients with acute myocardial infarction treated with thrombolytic therapy and heparin: Results from the gusto-i trial Journal of the American College of Cardiology  1998 31:497-505  DOI:10.1016/s0735-1097(97)00539-1  PMID:9502626
  • Zabel, K. M., Granger, C. B., Becker, R. C., Bovill, E. G., Hirsh, J., Aylward, P. E., Topol, E. J., Califf, R. M., Investigators, Gusto- I. Use of bedside activated partial thromboplastin time monitor to adjust heparin dosing after thrombolysis for acute myocardial infarction: Results of gusto-i American Heart Journal  1998 136:868-876  DOI:10.1016/s0002-8703(98)70133-4  PMID:9812083
  • Granger, C. B., Hirsh, J., Califf, R. M., Col, J., White, H. D., Betriu, A., Woodlief, L. H., Lee, K. L., Bovill, E. G., Simes, J., Topol, E. J. Activated partial thromboplastin time and outcome after thrombolytic therapy for acute myocardial infarction: Results for the gusto-i trial Circulation  1996 93:870-878  PMID:8598077